Venture group targets tech transfer deals in Texas

Emergent Technologies garnered $27.1 million in venture capital to license biotech research programs from the University of Texas. ETI has been operating in Texas for several years now. It specializes in identifying promising biotech research, licensing the technology and then spawning small start-up companies to advance the work. The company typically makes relatively small investments in each start-up and looks to larger pharma companies to come in and partner with them, providing much of the money necessary to grow the companies. Texas has lagged behind a large number of states that have seen their university research explode in recent years. The University of Florida system, meanwhile, has been one of the most active in the licensing arena.

- here's the report from the Austin American-Statesman

ALSO: A collaborative of scientists from South Florida and Latin America have begun seeking partners to advance their work in genomics. Report

Suggested Articles

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.

Efforts to pivot existing discoveries into COVID-19 cures may not bear fruit until the pandemic has ended but could help fend off future outbreaks.